IL17A and Other metabolic disease: As for the latter, it was recently associated with metabolic disorders [47,48] and suggested to play a role in altering intestinal permeability, contributing to a pro-inflammatory state through increased production of chemokines and IL-17A, even in other pathological contexts, such as rheumatoid arthritis [49].